Cancer chemotherapy based on evidence--metastatic breast cancer |
| |
Authors: | Takashima S Saeki T Ohsumi S |
| |
Affiliation: | Dept. of Surgery, National Shikoku Cancer Center Hospital, Matsuyama, Japan. |
| |
Abstract: | Breast cancer is relatively sensitive to chemotherapy. However, although response rate to chemotherapy is reported to be from 50 to 70% in metastatic breast cancer, it is incurable. Current standard chemotherapeutic regimens do not provide a large survival benefit according to the evidence obtained from clinical studies. Before developing a treatment program, we should therefore realize that the aims of chemotherapy for metastatic breast cancer are improvement of quality of life through relief of symptoms, and prolonging survival. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|